
Drug Manufacturers
Mallinckrodt Plc (NYSE:MNK) has reportedly brought in restructuring advisors as the company considers bankruptcy, plunging MNK stock by over 40%. The pharmaceutical firm has felt the burden of the opioid crisis more than most of ... [Read]